Log in to save to my catalogue

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7377258

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Two inoculations with a new SARS-CoV-2 mRNA-based vaccine that encodes a protein in the coronavirus spike elicited high titers of virus-neutralizing antibody in healthy adult volunteers. Virus-specific T-cell responses were also elicited. Interim findings indicated that a dose of 100 μg per injection maximized immune response and minimized the reac...

Alternative Titles

Full title

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7377258

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7377258

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2022483

How to access this item